Literature DB >> 7515104

Constitutive CD8 expression allows inefficient maturation of CD4+ helper T cells in class II major histocompatibility complex mutant mice.

E Robey1, A Itano, W C Fanslow, B J Fowlkes.   

Abstract

Although mature CD4+ T cells bear T cell receptors (TCRs) that recognize class II major histocompatibility complex (MHC) and mature CD8+ T cells bear TCRs that recognize class I MHC, it is possible that the initial commitment of an immature thymocyte to a CD4 or CD8 lineage is made without regard to the specificity of the TCR. According to this model, CD4+ cells with class I TCR do not mature because the CD8 coreceptor is required for class I MHC recognition and positive selection. If this model is correct, constitutive expression of CD8 should allow CD4+ T cells with class I-specific TCRs to develop. In this report, we show that mature peripheral CD4+ cells are present in class II MHC-deficient mice that express a constitutive CD8.1 transgene. These cells share a number of properties with the major class II MHC-selected CD4 population, including the ability to express CD40 ligand upon activation. Although mature CD4 cells are also detectable in the thymus of class II MHC mutant/CD8.1 transgenic mice, they represent a small fraction of the mature CD4 cells found in mice that express class II MHC. These results indicate that some T cells choose the CD4 helper lineage independent of their antigen receptor specificity; however, the inefficiency of generating class I-specific CD4 cells leaves open the possibility that an instructive signal generated upon MHC recognition may bias lineage commitment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515104      PMCID: PMC2191509          DOI: 10.1084/jem.179.6.1997

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

Authors:  B H Koller; P Marrack; J W Kappler; O Smithies
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

2.  T-cell development. Accessories or coreceptors?

Authors:  C A Janeway
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

3.  A subset of CD4+ thymocytes selected by MHC class I molecules.

Authors:  A Bendelac; N Killeen; D R Littman; R H Schwartz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

4.  Stochastic component to development of class I major histocompatibility complex-specific T cells.

Authors:  A Itano; D Kioussis; E Robey
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

5.  Separation of lymphocytes on antibody-coated plates.

Authors:  M G Mage
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

7.  T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages.

Authors:  C J Guidos; J S Danska; C G Fathman; I L Weissman
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

8.  Functional and phenotypic delineation of two subsets of CD4 single positive cells in the thymus.

Authors:  J Nikolić-Zugić; M J Bevan
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

9.  Mice lacking MHC class II molecules.

Authors:  D Cosgrove; D Gray; A Dierich; J Kaufman; M Lemeur; C Benoist; D Mathis
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

10.  Development of the CD4 and CD8 lineage of T cells: instruction versus selection.

Authors:  P Borgulya; H Kishi; U Müller; J Kirberg; H von Boehmer
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  10 in total

Review 1.  Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice.

Authors:  Alfred Singer; Stanley Adoro; Jung-Hyun Park
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

Review 2.  TCR-MHC docking orientation: natural selection, or thymic selection?

Authors:  Edward J Collins; David S Riddle
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Role of coreceptors in positive selection and lineage commitment.

Authors:  S H Chan; C Waltzinger; A Baron; C Benoist; D Mathis
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

4.  Stochastic coreceptor shut-off is restricted to the CD4 lineage maturation pathway.

Authors:  B Lucas; F Vasseur; C Penit
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

5.  Intermediate steps in positive selection: differentiation of CD4+8int TCRint thymocytes into CD4-8+TCRhi thymocytes.

Authors:  K Lundberg; W Heath; F Köntgen; F R Carbone; K Shortman
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

6.  Lineage commitment in the thymus: only the most differentiated (TCRhibcl-2hi) subset of CD4+CD8+ thymocytes has selectively terminated CD4 or CD8 synthesis.

Authors:  J A Punt; H Suzuki; L G Granger; S O Sharrow; A Singer
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

Review 7.  CD4/CD8 lineage commitment: back to instruction?

Authors:  H von Boehmer
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

8.  Visualization of CD4/CD8 T cell commitment.

Authors:  S Chan; M Correia-Neves; A Dierich; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

9.  Human CD8 transgene regulation of HLA recognition by murine T cells.

Authors:  D M LaFace; M Vestberg; Y Yang; R Srivastava; J DiSanto; N Flomenberg; S Brown; L A Sherman; P A Peterson
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells.

Authors:  A Itano; P Salmon; D Kioussis; M Tolaini; P Corbella; E Robey
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.